"10.1371_journal.pone.0061002","plos one","2013-04-18T00:00:00Z","Mary A De Groote; Payam Nahid; Leah Jarlsberg; John L Johnson; Marc Weiner; Grace Muzanyi; Nebojsa Janjic; David G Sterling; Urs A Ochsner","SomaLogic, Inc., Boulder, Colorado, United States of America; Department of Microbiology, Immunology and Pathology, Colorado State University Campus, Fort Collins, Colorado, United States of America; Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, United States of America; Tuberculosis Research Unit, Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio, United States of America; Division of Infectious Diseases, University of Texas Health Science Center, San Antonio, Texas, United States of America; Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda","Performed sample procurement and provided the clinical data: LJ PN MW JJ GM. Initiated and coordinated TB efforts at SomaLogic: MADG. Leading the Infectious Disease/Microbiology programs at SomaLogic: UO. Chief Science Officer and oversaw the project: NJ. Conceived and designed the experiments: PN UO MADG. Performed the experiments: DS UO MADG. Analyzed the data: UO MADG DS. Contributed reagents/materials/analysis tools: UO NJ DS PN MW. Wrote the paper: MADG PN UO.","NJ, DS and UO are employees and shareholders of SomaLogic, Inc. MAD is a Consultant to SomaLogic, Inc. The entire sample analysis was funded by SomaLogic, Inc. A provisional patent has been filed by SomaLogic. The patent name is “Tuberculosis Biomarkers and Uses Thereof”, and the application number is 61/623,732. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Mary A De Groote","MADG",9,TRUE,3,5,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
